Dr Peter Szlosarek talks about the ADAM trial in the 2012 IMig Meeting, Boston, US

Kaye Yeung Posted in Conferences, BCI on the Road 11 September 2012

Peter_Szlosarek__sep_2012_boston_IMIG

 

Dr Peter Szlosarek will be speaking at the 2012 IMig (International Mesothelioma Interest Group) Meeting on Thursday 13 September 2012, (Session IVB).

His talk is entitled 'Arginine deprivation with pegylated arginine deiminase (ADI-PEG20) in patients with malignant pleural mesothelioma (MPM): preliminary results of a multicenter randomized phase II trial'.

'The iMig is an independent international group of scientists and clinicians working to understand, cure and prevent Mesothelioma.'

Leave a comment

You are commenting as guest. Optional login below.

This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.